June 2025

VADDRx Symposium 2025

April 2025

Computational Medicinal Chemistry Symposium

March 2025

Novel PROTACs Targeting FOSL1 Degradation to Eliminate HNSCC Cancer Stem Cells: From a Drug Discovery and Development Perspective

Yan Zhang, Ph.D.

March 2025

Targeting TAM Kinases for Cancer Treatment

Xiaodong Wang, Ph.D.

February 2025

Defying Conventional Wisdom: Developing Carbon Monoxide as a Therapeutic Agent

Binghe Wang, Ph.D.

May 2024

VaDrugDiscoveryRx 2024: From Discovery to Development

July 2018

Towards Validation of NS4A Competitors as HCV NS3/4A Allosteric Inhibitors

Summer Seminar

March 2018

Identifying the Small Signaling Molecules that Mediate Antibiotic Tolerance in Clostridium Difficile

Erin B. Purcell, Ph.D.

March 2018

How GPCR Structural Insights Accelerate Drug Discovery

Bryan L. Roth, Ph.D.

February 2018

New Technologies and Methods for Controlling Crystal Nucleation and Growth

Mo Jiang, Ph.D.

November 2017

Insights into the Control of TRPV2 Channel Activity in Microglia and Peripheral Leukocytes by ROS and Cannabinoid Ligands

Ian S. Ramsey, Ph.D.

November 2017

Protein Tyrosine Phosphatases as Emerging Cancer Therapeutic Targets

John Lazo, Ph.D.

October 2017

Illuminating Biology with Genetically Encoded Biosensors

Hui-Wang Ai, Ph.D.

September 2017

Roles of Mucins in Respiratory Tract Inflammation

Kwang Chul Kim, Ph.D.

August 2017

Interactions of Pleiotrophin with Glycosaminoglycans

Xu Wang, Ph.D.

May 2017

Target Validation of Calpain-1 as a Novel Regulator of Platelet Hyperactivity and Pain Sensitivity in a Humanized Mouse Model of Severe Sickle Cell Disease

Jen Nwankwo, Ph.D.

May 2017

Dendrimer Nanocarries for Transport Modulation Across the Pulmonary Epithelium

Sandro da Rocha, Ph.D.

April 2017

Targeting a Bacterial Metabolic Branch Point through Inhibition of DXP Synthase

Caren L. Freel Meyers, Ph.D.

April 2017

Research Funding by the National Cancer Institute: An Insider's Perspective

Karl Krueger, Ph.D.

March 2017

Statins Inhibit Mast Cell-Mediated Inflammation

John J. Ryan, Ph.D.

March 2017

Genes and Epigenetic Mechanisms Mediating Central Nervous System Drug Response

Joseph McClay, Ph.D.

February 2017

Chemical Approaches for Characterizing Protein Glutathionylation

Young-Hoon Ahn, Ph.D.

January 2017

Structural and Biochemical Studies of HSP 70 Molecular Chaperones

Qinglian Liu, Ph.D.

November 2016

Innate Pattern Recognition Receptors as Potential Therapeutic Targets in Cancer and Inflammatory Diseases

Xiang-Yang Wang, Ph.D.

November 2016

Illuminating the Path for Cell Signaling and Drug Delivery

David S. Lawrence, Ph.D.

November 2016

A Regulatory Enzyme Complex for Glucose Metabolism in Living Cells: The Glucose

Songon An, Ph.D.

October 2016

Resolution of Oxidative Damage at DNA Ends in Double-Strand Break Repair

Lawrence Povirk, Ph.D.

October 2016

Drug Discovery in Academia

Donald J. Abraham, Ph.D.

September 2016

Mitochondrial Epigenetics and Transcription Control

Shirley Taylor, Ph.D.

September 2016

Small Molecule Inhibitors of the BCL6 BTB Domain for the Treatment of Diffuse Large B-cell Lymphoma

Fengtian Xue, Ph.D.